Free Trial
NASDAQ:LFST

LifeStance Health Group (LFST) Stock Price, News & Analysis

LifeStance Health Group logo
$4.26 -0.16 (-3.60%)
As of 03:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About LifeStance Health Group Stock (NASDAQ:LFST)

Key Stats

Today's Range
$4.24
$4.45
50-Day Range
$4.40
$6.06
52-Week Range
$4.25
$8.61
Volume
1.45 million shs
Average Volume
1.68 million shs
Market Capitalization
$1.66 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Moderate Buy

Company Overview

LifeStance Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

LFST MarketRank™: 

LifeStance Health Group scored higher than 61% of companies evaluated by MarketBeat, and ranked 428th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 4 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    LifeStance Health Group has only been the subject of 1 research reports in the past 90 days.

  • Read more about LifeStance Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeStance Health Group are expected to grow in the coming year, from ($0.18) to ($0.14) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeStance Health Group is -42.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeStance Health Group is -42.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LifeStance Health Group has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about LifeStance Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    7.44% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently decreased by 6.37%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    LifeStance Health Group does not currently pay a dividend.

  • Dividend Growth

    LifeStance Health Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.44% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently decreased by 6.37%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    LifeStance Health Group has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for LifeStance Health Group this week, compared to 3 articles on an average week.
  • Search Interest

    15 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,040.00 in company stock.

  • Percentage Held by Insiders

    Only 3.20% of the stock of LifeStance Health Group is held by insiders.

  • Percentage Held by Institutions

    85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LifeStance Health Group's insider trading history.
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

LFST Stock News Headlines

Elon Just Fired the IRS Agents Targeting Your Savings
Elon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regain control, one overlooked IRS “backdoor” still allows retirement savers to protect their wealth — penalty-free and tax-free. A free 2025 guide reveals how to use it before it’s too late.
See More Headlines

LFST Stock Analysis - Frequently Asked Questions

LifeStance Health Group's stock was trading at $7.37 at the beginning of the year. Since then, LFST shares have decreased by 42.1% and is now trading at $4.2650.

LifeStance Health Group, Inc. (NASDAQ:LFST) posted its quarterly earnings results on Thursday, November, 7th. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.05. The business's revenue was up 18.9% compared to the same quarter last year.
Read the conference call transcript
.

LifeStance Health Group (LFST) raised $640 million in an IPO on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

LifeStance Health Group's top institutional shareholders include Public Employees Retirement System of Ohio and Park Edge Advisors LLC. Insiders that own company stock include Summit Partners Growth Equity, Warren Gouk, Kevin Michael Mullins, Robert Bessler, Ryan Pardo, Danish J Qureshi, David Bourdon, Lisa K Miller, Anisha Patel-Dunn, Ann Varanakis, Paula Cipollone and Ujjwal Ramtekkar.
View institutional ownership trends
.

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
11/07/2024
Today
7/18/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFST
CIK
1845257
Fax
N/A
Employees
10,218
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$7.00
Potential Upside/Downside
+99.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.44 million
Net Margins
-2.78%
Pretax Margin
-2.99%
Return on Equity
-2.47%
Return on Assets
-1.69%

Debt

Debt-to-Equity Ratio
0.19
Current Ratio
1.47
Quick Ratio
1.47

Sales & Book Value

Annual Sales
$1.25 billion
Price / Sales
1.33
Cash Flow
$0.04 per share
Price / Cash Flow
110.96
Book Value
$3.78 per share
Price / Book
1.13

Miscellaneous

Outstanding Shares
388,880,000
Free Float
376,432,000
Market Cap
$1.66 billion
Optionable
Optionable
Beta
1.16
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:LFST) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners